Errol L. Bush

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Justina X. Caushi, Jiajia Zhang, Zhicheng Ji et al. · Nature · 2021 · 547 citations · Full text

Life Sciences, Immunology, Oncology +17

Epigenetic therapy inhibits metastases by disrupting premetastatic niches

Zhihao Lü, Jianling Zou, Shuang Li et al. · Nature · 2020 · 337 citations · Full text

Medicine, Cancer Biology, Oncology +14

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

Matthew J. Bott, Stephen C. Yang, Bernard J. Park et al. · Journal of Thoracic and Cardiovascular Surgery · 2018 · 302 citations · Full text

Medicine, Oncology, Surgery +16

Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation

Jonathan P. Singer, Joshua M. Diamond, Cynthia Gries et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 216 citations · Full text

Medicine, Geriatric Medicine, Frailty +16

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Joshua E. Reuss, Valsamo Anagnostou, Tricia R. Cottrell et al. · Journal for ImmunoTherapy of Cancer · 2020 · 163 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17